| Drug Name |
Sodium ferric gluconate complex |
| Drug ID |
BADD_D02038 |
| Description |
Sodium ferric gluconate complex is an iron replacement product for treatment of iron deficiency anemia. The stable macromolecular complex is negatively charged at alkaline pH with an apparent molecular weight of 289,000 – 440,000 daltons on gel chromatography. It is composed of iron (III) oxide hydrate directly bonded to sucrose with a chelating gluconate function in a molar ratio of two iron molecules to one gluconate. It is used in adult and in pediatric patients over the age of 6 years with chronic kidney disease (CKD) receiving hemodialysis and receiving supplemental epoetin therapy. |
| Indications and Usage |
Used to replete the total body content of iron during iron deficiency anemia in patients age 6 years and older with chronic kidney disease receiving hemodialysis and receiving supplemental epoetin therapy. |
| Marketing Status |
approved |
| ATC Code |
Not Available |
| DrugBank ID |
DB09517
|
| KEGG ID |
D05859
|
| MeSH ID |
C035552
|
| PubChem ID |
23693558
|
| TTD Drug ID |
D0VM8K
|
| NDC Product Code |
0024-2794; 0024-2792; 44498-001; 68022-7505 |
| UNII |
CC9149U2QX
|
| Synonyms |
ferric gluconate | ferric gluconate trihydrate | ferric gluconate anhydrous | sodium iron(III)gluconate | sodium ferrigluconate | ferric gluconate, sodium salt | Ferrlecit | Ferrlecit 100 |
